Potential for earlier diagnosis of ovarian cancer
(Medical Xpress) -- Australian scientists have identified biochemical changes that commonly occur in the DNA of women with ovarian cancer, which may help diagnose the cancer at an earlier stage in the future.
Using whole genome DNA profiling methods, Brian Gloss, Dr Philippa OBrien and Professor Susan Clark from Sydneys Garvan Institute of Medical Research have identified a panel of 6 genes that are affected by an epigenetic process known as DNA methylation in ovarian cancer.
The Garvan team collaborated with Professor Neville Hacker, Director Gynaecological Cancer Unit, Royal Hospital for Women Randwick, who provided tumour samples from ovarian cancer patients, as well as tissue samples from normal ovaries.
The findings are published in the journal Cancer Letters, now online.
Ovarian cancer is not easily diagnosed early, and people with advanced disease tend to die quickly.
Women diagnosed at a late stage the majority have a 30% 5-year survival rate. Women diagnosed at an early stage have a 90% 5-year survival rate.
Although ovarian cancer is a relatively rare disease, it is the leading cause of death due to gynaecological cancers, and the sixth leading cause of cancer death in women. Around one in 70 women will develop the cancer, and around one in 100 women will die from it.
Ovarian cancers are usually diagnosed once the disease has spread past the pelvis and into other organs including the stomach, bowel and lungs. They are typically very hard to get rid of with surgery and they tend to become rapidly resistant to chemotherapeutics.
This was one of first studies that used whole genome techniques to directly profile DNA methylation aberrations in ovarian cancer - with the aim of identifying diagnostic biomarkers, said Brian Gloss, who focused on the project for his PhD.
When we started in 2008, most other research groups were investigating single genes known to be methylated in other cancers. We decided to make use of new whole genome technologies using DNA methylation profiling and gene expression profiling.
We wanted to see exactly which methylation changes led directly to aberrant gene silencing. In other words, which methylation changes have a functional role in ovarian cancer.
We did our discovery process in cell lines and then validated our findings in 27 cancers versus 12 normal ovarian tissue samples.
One of the key methylated genes we identified was a novel gene, which had not been identified as being misregulated in any cancer before.
When we then analysed a further 100 tumours, we found that the novel biomarker gene was methylated in 80% of them.
This paper represents the first half of our work. The next step will be to see how our panel of biomarker genes is methylated in a larger cohort of ovarian tumours, and to identify the function of our novel gene.
The most difficult aspect of ovarian cancer is that it is a molecularly heterogeneous disease, meaning that each tumour can be quite different from the next.
We need to show, therefore, that our panel of biomarkers will be a sufficiently rigorous diagnostic tool, able to catch the requisite number of tumours.
More information: www.mendeley.com/r… l-novel-pan/
Provided by Garvan Institute of Medical Research
-
Unique genetic marker may improve detection of recurrent ovarian cancer
Dec 07, 2011 |
not rated yet |
0
-
Evolving ovarian cancer cells 'dodge' treatment with chemotherapy
Dec 20, 2011 |
not rated yet |
0
-
New test for ovarian cancer patients
Nov 09, 2010 |
not rated yet |
0
-
Ovarian cancer advances when genes are silenced
Dec 13, 2010 |
not rated yet |
0
-
Pill and pregnancy have biggest effects on ovarian cancer risk
Oct 26, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
New fluorescent tools for cancer diagnosis
In recent years, microRNAs (miRNAs) and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers. miRNA profiles have been used ...
Cancer
4 hours ago |
not rated yet |
0
Modulating the immune system to combat metastatic cancer
Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ...
Cancer
4 hours ago |
not rated yet |
0
Scientists put bowel cancer under the microscope
Researchers from London's Kingston University have begun a two-year study which could help prolong the lives of people with colorectal tumours.
Cancer
7 hours ago |
5 / 5 (1) |
0
Researcher identifies breast cancer fighting hormone
Transformative research from Western University has identified new hormones in the body which may suppress breast cancer and stimulate the regression of breast tumors.
Cancer
8 hours ago |
5 / 5 (1) |
0
Ground breaking cancer research finds immune system link
(Medical Xpress)—Curtin University researchers have found evidence that targeting specific cells in the body can reverse the effects of cancer on the immune system.
Cancer
8 hours ago |
5 / 5 (3) |
0
Engineered cytomegalovirus protects monkeys from HIV equivalent
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
Researchers identify first drug targets in childhood genetic tumor disorder
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
Hormone levels may provide key to understanding psychological disorders in women
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
Going live: Immune cell activation in multiple sclerosis
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
Driving and hands-free talking lead to spike in errors, study shows
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.
Controlling mood through the motions of mitochondria
(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...